Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Enteral Stents Market Revenue Growth Supported By A CAGR Of 2.21% Through 2030

The market for enteral stents has demonstrated robust expansion in recent times, with projections indicating a substantial increase from $1.55 billion in 2025 to $1.67 billion by 2026, reflecting a compound annual growth rate of 7.7%. This historical growth trajectory can be linked to several key factors, including the increasing incidence of gastrointestinal cancers, a rise in instances of bowel obstruction, greater utilization of endoscopic procedures, advancements in hospital gastrointestinal infrastructure, and a growing demand for palliative care services.

The market for enteral stents is poised for considerable expansion over the coming years, projecting an increase to $2.22 billion by the year 2030, driven by a compound annual growth rate of 7.4%. This anticipated growth is largely fueled by several key factors including the demographic shift towards an older population, the increasing preference for minimally invasive surgical techniques, advancements in biodegradable stent technology, the broadening scope of cancer treatments, and enhanced access to sophisticated gastrointestinal care. During this projected period, significant market dynamics are expected to emerge, such as a growing inclination towards less invasive gastrointestinal interventions, a greater reliance on devices for palliative cancer care, a surge in the deployment of self-expanding metal stents, an enlarged focus on gastrointestinal oncology therapies, and an emphasis on ensuring sustained patency within the lumens.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20774&type=smp

Enteral Stents Market Opportunity Drivers: What Is Creating New Revenue Potential?

The expanding occurrence of digestive system ailments is poised to stimulate the enteral stents market’s expansion. These ailments encompass a broad spectrum of conditions affecting organs like the esophagus, stomach, and intestines, manifesting as pain and discomfort. Factors contributing to this rise include detrimental eating patterns, heightened stress, inactive lifestyles, increased antibiotic consumption, and greater exposure to environmental toxins. Enteral stents serve a crucial role in managing these disorders by providing a less invasive approach to alleviating blockages, reinstating the normal passage of food and fluids, and ultimately improving digestive function, patient comfort, and quality of life. For example, Crohn’s and Colitis Canada reported in June 2023 that an estimated 322,600 Canadians, representing 0.8% of the population, had Inflammatory Bowel Disease (IBD) in 2023, with projections suggesting this number could climb to 470,000 (1.1% of the population) by 2035. Consequently, the growing incidence of gastrointestinal disorders is a key driver for the enteral stent market.

The increasing incidence of cancer is anticipated to fuel the expansion of the enteral stents market. Cancer, a set of diseases defined by the uncontrolled proliferation and dissemination of aberrant cells, is on the rise due to an aging global population, lifestyle choices, advancements in diagnostic technologies, inherited genetic factors, and improved access to and awareness of healthcare. Enteral stents are instrumental in addressing gastrointestinal blockages that arise from cancer, thereby mitigating symptoms like difficulty swallowing and ensuring adequate nutritional intake. Illustratively, the World Health Organization projected in February 2024 that by 2050, the world would witness over 35 million new cancer diagnoses, a substantial 77% increase from the approximately 20 million cases recorded in 2022. Therefore, the escalating rate of cancer diagnoses is a significant contributor to the enteral stents market’s growth.

Enteral Stents Market Segment Outlook: Which Categories Are Expanding The Fastest?

The enteral stents market covered in this report is segmented –

1) By Stent Type: Esophageal Stents, Gastroduodenal Stents, Colon Stents

2) By Material Type: Self-Expandable Plastic Stents, Self-Expandable Metal Stents

3) By End User: Hospitals, Specialty Clinics, Ambulatory Centers, Research Centers

Subsegments:

1) By Esophageal Stents: Self-Expanding Metal Esophageal Stents, Covered Esophageal Stents, Uncovered Esophageal Stents, Hybrid Esophageal Stents, Temporary Esophageal Stents

2) By Gastroduodenal Stents: Self-Expanding Metal Gastroduodenal Stents, Covered Gastroduodenal Stents, Uncovered Gastroduodenal Stents, Biodegradable Gastroduodenal Stents

3) By Colon Stents: Self-Expanding Metal Colon Stents, Covered Colon Stents, Uncovered Colon Stents, Biodegradable Colon Stents, Colon Stents For Colonic Obstruction

Enteral Stents Market Key Companies And Competitive Benchmarking

Major companies operating in the enteral stents market are Cardinal Health Inc., Medtronic Inc., Boston Scientific Corporation, Olympus Corporation, Lepu Medical Technology (Beijing) Co Ltd., Endo-Therapeutics Inc., Cook Medical, Micro-Tech (Nanjing) Co Ltd., Merit Medical Systems Inc., ConMed Corporation, Medi-Globe GmbH, Taewoong Medical Inc., ELLA-CS s.r.o., S&G Biotech Inc., Nanwei Medical Technology Co Ltd, M I Tech Co Ltd, ACE Medical Devices Pvt Ltd, Allium Ltd, ENDOCOR GmbH & Co KG, Sewoon Medical Co Ltd, Changzhou Health Microport Medical Device Co Ltd, Medorah Meditek Pvt Ltd, Advin Health Care, ENDO-FLEX GmbH, CITEC, QualiMed, W L Gore & Associates Inc., Becton Dickinson and Company

Access The Complete Enteral Stents Market Report:

https://www.thebusinessresearchcompany.com/report/enteral-stents-global-market-report

Enteral Stents Market Regional Analysis And Leading Geography

North Americawas the largest region in the enteral stents market in 2025. The regions covered in the enteral stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model